StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3065% below fair value
$0.84−0.04 (-4.65%)

Close on Nov 19, 2026Market cap $30.35MP/E 8.4Yield –

biote free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

biote's free cash flow for the twelve months ending Jun 30, 2026 was $19.87M, down 42.9% year over year. For fiscal 2025 it was $30.18M, down 22.2% from the year before. The highest annual figure on record is $38.81M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.18M-22.2%
FY2024Dec 31, 2024$38.81M+46.3%
FY2023Dec 31, 2023$26.52M–
FY2022Dec 31, 2022-$9.49M-129.4%
FY2021Dec 31, 2021$32.27M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.73M-170.7%
Q1 FY2026Mar 31, 2026$3.54M-26.8%
Q4 FY2025Dec 31, 2025$6.49M-39.3%
Q3 FY2025Sep 30, 2025$13.57M-3.1%
Q2 FY2025Jun 30, 2025$5.28M-29.1%
Q1 FY2025Mar 31, 2025$4.84M-27.5%
Q4 FY2024Dec 31, 2024$10.70M+50.4%
Q3 FY2024Sep 30, 2024$14.01M–
Q2 FY2024Jun 30, 2024$7.44M+9.9%
Q1 FY2024Mar 31, 2024$6.67M-48.4%
Q4 FY2023Dec 31, 2023$7.12M+17.7%
Q3 FY2023Sep 30, 2023-$291.00K-104.6%
Q2 FY2023Jun 30, 2023$6.77M–
Q1 FY2023Mar 31, 2023$12.93M+92.8%
Q4 FY2022Dec 31, 2022$6.05M-35.7%
Q3 FY2022Sep 30, 2022$6.39M-2.7%
Q2 FY2022Jun 30, 2022-$28.64M–
Q1 FY2022Mar 31, 2022$6.71M–
Q4 FY2021Dec 31, 2021$9.41M–
Q3 FY2021Sep 30, 2021$6.57M–

More biote figures

See a number that looks wrong?